Search Results - Rubio-Rodrfguez, Darfo

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Costs of adverse events associated with erlotinib or afatinib in first-line treatment of advanced EGFR-positive non-small cell lung cancer

    Costs of adverse events associated with erlotinib or afatinib in first-line treatment of advanced EGFR-positive non-small cell lung cancer by Isla, Dolores, De Castro, Javier, Juan, Oscar, Grau, Santiago, Orofino, Javier, Gordo, Rocío, Rubio-Terrés, Carlos, Rubio-Rodríguez, Darío

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Costs of adverse events associated with erlotinib or afatinib in first-line treatment of advanced EGFR-positive non-small cell lung cancer

    Costs of adverse events associated with erlotinib or afatinib in first-line treatment of advanced EGFR-positive non-small cell lung cancer by Isla, Dolores, Castro, Javier De, Juan, Oscar, Grau, Santiago, Orofino, Javier, Gordo, Rocfo, Rubio-Terres, Carlos, Rubio-Rodrfguez, Darfo

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: